منابع مشابه
Dialysis and Transplantation News Renal transplantation in Iran
Iran—formerly called Persia—is located in the Middle East between the Caspian Sea and the Persian Gulf. It covers 1 648 000 km and has 60 million inhabitants. The prevalence of end-stage renal disease (ESRD) patients in Iran is about 15 000 and the annual incidence of new ESRD patients is 3175 or 53 patients per million populations per year. Iran has the most successful renal transplant program...
متن کاملSeizure disorders after renal Transplantation in children
Background and Objective: Some neurologic complications may be detected after renal transplantation in children including tremor, peripheral neuropathy, altered level of consciousness and seizure. The aim of our study was to detect the prevalence of seizure after renal transplantation and its risk factors in pediatric age groups. Methods: In this descriptive study, 102 patients 5-14 yea...
متن کاملRenal transplantation outcome in children with cystinosis
Background and Objective: Cystinosis is a rare inherited disease that leads to renal failure. Fanconi syndrome is the major renal involvement in cystinosis patients. Renal transplantation is the treatment of choice in cystinosis children with end-stage renal disease (ESRD). The study aimed to assess the outcome of renal transplantation in Iranian children with cystinosis. Methods: This...
متن کاملKidney Transplantation in Iran
Kidney transplantation in patients with end stage renal disease is preferred to dialysis because transplantation provides a better quality of life andimproved survival. However, the gap between the supply and demand for a renal allograft is widening and the waiting time is increasing. Iranian protocol, a controlled transplant program supported by the government for living unrelated donors, was ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Nephrology Dialysis Transplantation
سال: 2002
ISSN: 1460-2385,0931-0509
DOI: 10.1093/ndt/17.2.222